Vimarsana.com

Latest Breaking News On - Regeneron pharmaceuticals trading - Page 1 : vimarsana.com

Commerce Bank Buys 257 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Commerce Bank raised its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 4.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 6,217 shares of the biopharmaceutical company’s stock after acquiring an additional 257 shares during the period. Commerce Bank’s holdings in […]

United-states
America
Leonards-schleifer
Marion-mccourt
News-ratings-for-regeneron-pharmaceuticals-daily
Insider-transactions-at-regeneron-pharmaceuticals
Annis-gardner-whiting-capital-advisors
Regeneron-pharmaceuticals-inc
Fortitude-family-office
Cantor-fitzgerald
Nasdaq
Sutton-wealth-advisors-inc

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S cut its holdings in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 52.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,494 shares of the biopharmaceutical company’s stock after selling 4,978 shares during the quarter. BI […]

United-states
America
Arthurf-ryan
Josephj-larosa
Exchange-commission
Securities-exchange-commission
Regeneron-pharmaceuticals-company-profile
News-ratings-for-regeneron-pharmaceuticals-daily
Cantor-fitzgerald
Regeneron-pharmaceuticals-inc
Morgan-stanley

ING Groep NV Has $24.87 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

ING Groep NV reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 20.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,311 shares of the biopharmaceutical company’s stock after selling 7,484 shares during the period. ING Groep […]

Leonards-schleifer
Regeneron-pharmaceuticals
Regeneron-pharmaceuticals-trading
Stifel-financial-corp
Regeneron-pharmaceuticals-inc
Regeneron-pharmaceuticals-company-profile
Monetary-management-group-inc
Exchange-traded-concepts
News-ratings-for-regeneron-pharmaceuticals-daily
Exchange-commission
Meyer-handelman-co

Nvwm LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Nvwm LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
America
Marion-mccourt
Andrewj-murphy
Regeneron-pharmaceuticals-trading
Quarter-for-regeneron-pharmaceuticals
Securities-exchange-commission
Regeneron-pharmaceuticals-inc
Barclays
News-ratings-for-regeneron-pharmaceuticals-daily
Regeneron-pharmaceuticals

UNIVEST FINANCIAL Corp Has $6.16 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

UNIVEST FINANCIAL Corp Has $6.16 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Andrewj-murphy
Bonniel-bassler
Regeneron-pharmaceuticals
Regeneron-pharmaceuticals-company-profile
Morgan-stanley
Sutton-wealth-advisors-inc
Eudaimonia-advisors
News-ratings-for-regeneron-pharmaceuticals-daily
Capital-management-inc
Regeneron-pharmaceuticals-inc
Exchange-commission

Retirement Systems of Alabama Sells 525 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Retirement Systems of Alabama Sells 525 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Alabama
United-states
Andrewj-murphy
Arthurf-ryan
Barclays
Cantor-fitzgerald
Securities-exchange-commission
Fortitude-family-office
Regeneron-pharmaceuticals-inc
News-ratings-for-regeneron-pharmaceuticals-daily
Nasdaq

California Public Employees Retirement System Lowers Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

California Public Employees Retirement System Lowers Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

California
United-states
Canada
American
Marion-mccourt
Arthurf-ryan
American-century-companies-inc
Northern-trust-corp
Morgan-stanley
Royal-bank
Regeneron-pharmaceuticals-inc
California-public-employees-retirement-system

New York State Common Retirement Fund Has $131.92 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

New York State Common Retirement Fund Has $131.92 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Marion-mccourt
Sanfordc-bernstein
Andrewj-murphy
Cantor-fitzgerald
Barclays
Regeneron-pharmaceuticals
Criterion-capital-advisors
Regeneron-pharmaceuticals-inc
Securities-exchange-commission
Nasdaq

abrdn plc Buys 186,215 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

abrdn plc Buys 186,215 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Bonniel-bassler
Sanfordc-bernstein
Josephl-goldstein
Nasdaq
Regeneron-pharmaceuticals
Securities-exchange-commission
Morgan-stanley
Regeneron-pharmaceuticals-company-profile
Barclays

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $970.57 Consensus Price Target from Analysts

Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the nineteen research firms that are currently covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and fourteen have given a […]

Josephl-goldstein
Andrewj-murphy
Sanfordc-bernstein
Eudaimonia-advisors
Analyst-recommendations-for-regeneron-pharmaceuticals
Insider-activity-at-regeneron-pharmaceuticals
Capital-management-inc
Nasdaq
Regeneron-pharmaceuticals-trading
Ronald-blue-trust-inc
Regeneron-pharmaceuticals-inc

vimarsana © 2020. All Rights Reserved.